Abbott | ABT - Assets

Stock Price
91.13
Daily Change
-1.35 -1.46%
Monthly
-13.07%
Yearly
-29.27%
Q2 Forecast
89.18

Abbott reported $86.71B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Agilent USD 12.81B 86M Dec/2025
AtriCure USD 654.18M 18.74M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Bio-Rad Laboratories USD 10.58B 880.1M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Cooper Companies USD 12.42B 29.4M Dec/2025
Danaher USD 83.54B 80M Mar/2026
Dexcom USD 6.34B 1.16B Dec/2025
Edwards Lifesciences USD 13.7B 425M Dec/2025
Globus Medical USD 5.3B 207.12M Dec/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.6B 44.45M Dec/2025
Intuitive Surgical USD 20.11B 347.7M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Masimo USD 1.7B 118.6M Dec/2025
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.69B 54.92M Dec/2025
Pfizer USD 208.73B 2.64B Sep/2025
Smith & Nephew USD 10.69B 150M Dec/2025
Solventum Corp USD 14.29B 321M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 6.95B 924.7M Dec/2025
Terumo JPY 2.26T 362.12B Dec/2025
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025